Centre Hospitalier Universitaire de Nantes

Centre Hospitalier Universitaire de Nantes is a university in Nantes, France that has taken part in 28 EU-funded projects since 2008, receiving €11.7M in EU funding and leading 1 as coordinator.

EU funding received€11.7M
EU projects28
As coordinator1
Running now13
First EU project2008
Latest project2027
CountryFrance
EU registration (PIC)999915868
On this page · 5 sections→

Where the EU money came from

Funding by EU programme. Amounts are Centre Hospitalier Universitaire de Nantes's own share of each project, not the project's full budget.

  • Horizon 2020€5.6M · 7 projects
  • FP7 (2007 to 2013)€3.1M · 7 projects
  • Horizon Europe€1.8M · 7 projects
  • EU4Health Programme (EU4H)€1.1M · 7 projects

Projects

28 EU-funded projects, newest first. Centre Hospitalier Universitaire de Nantes led 1 of them as coordinator. Each links to the official record.

  • ChronoBridgeAssociated partner

    Bridging Chronobiology and Physiology through Expert Training

    Horizon Europe · 2027–2030 · Project on CORDIS ↗

  • TOGAS PlusPartner

    Advancing gastric cancer screening implementation in Europe

    EU4Health Programme (EU4H) · 2026–2029 · Project on the EU portal ↗

    €106ktheir share
  • PanCare4AYAAssociated partner

    Patient-centred, evidence-based late effect screening and follow-up care of survivors of adolescent and young adult cancer

    Horizon Europe · 2025–2030 · Project on CORDIS ↗

  • BREATHAssociated partner

    BRinging hEAlTH and social sciences to a new level through an interdisciplinary doctoral programme

    Horizon Europe · 2025–2029 · Project on CORDIS ↗

  • ORCHIDEEAssociated partner

    « ORCHIDEE » Project - Developing a New National Epidemiological Surveillance Hospital Network through Secondary Health Data Usage in Hospitals

    EU4Health Programme (EU4H) · 2024–2028 · Project on the EU portal ↗

    €133ktheir share
  • EUnetCCC JAAssociated partner

    The European Comprehensive Cancer Centre Network

    EU4Health Programme (EU4H) · 2024–2028 · Project on the EU portal ↗

    €6ktheir share
  • MULTIRPartner

    MULti-Tumour based prediction and manipulation of Immune Response

    Horizon Europe · 2024–2027 · Project on CORDIS ↗

    €301ktheir share
  • Homi-lungPartner

    Long-term alterations of host-microbiome interactions and cardiovascular and respiratory diseases progression after pneumonia

    Horizon Europe · 2024–2028 · Project on CORDIS ↗

    €914ktheir share
  • EU-JAMRAI 2Associated partner

    Joint Action Antimicrobial Resistance and Healthcare-Associated Infections 2

    EU4Health Programme (EU4H) · 2024–2027 · Project on the EU portal ↗

    €183ktheir share
  • JACARDIAssociated partner

    Joint Action on CARdiovascular diseases and DIabetes

    EU4Health Programme (EU4H) · 2023–2027 · Project on the EU portal ↗

    €284ktheir share
  • NaV1.5-CAREDPartner

    NaV1.5 regulation fine-tuning as a therapy for cardiac Conduction and Arrhythmic diseases at Risk of suddEn Death

    Horizon Europe · 2023–2028 · Project on CORDIS ↗

    €178ktheir share
  • TOGASPartner

    TOWARDS GASTRIC CANCER SCREENING IMPLEMENTATION IN THE EUROPEAN UNION

    EU4Health Programme (EU4H) · 2023–2026 · Project on the EU portal ↗

    €334ktheir share
  • AIDAPartner

    An Artificially Intelligent Diagnostic Assistant for gastric inflammation

    Horizon Europe · 2023–2026 · Project on CORDIS ↗

    €454ktheir share
  • EUROHELICANPartner

    Accelerating gastric cancer reduction in Europe through Helicobacter pylori eradication

    EU4Health Programme (EU4H) · 2022–2025 · Project on the EU portal ↗

    €68ktheir share
  • HAP2Coordinator

    Host-targeted Approaches for the Prevention and the treatment of Hospital-Acquired Pneumonia

    Horizon 2020 · 2020–2026 · Project on CORDIS ↗

    €4.0Mtheir share
  • RESHAPEAssociated partner

    Reshaping undesired Inflammation in challenged Tissue Homeostasis by Next-Generation regulatory T cell (Treg) Approaches – from Advanced Technology Developments to First-in-Human Trials

    Horizon 2020 · 2019–2024 · Project on CORDIS ↗

    €5ktheir share
  • EU-TRAINPartner

    The EUropean TRAnsplantation and INnovation (EU-TRAIN) consortium for improving diagnosis and risk stratification in kidney transplant patients

    Horizon 2020 · 2018–2024 · Project on CORDIS ↗

    €891ktheir share
  • MAXIBONEPartner

    Personalised maxillofacial bone regeneration

    Horizon 2020 · 2018–2022 · Project on CORDIS ↗

    €161ktheir share
  • RESPINEPartner

    REgenerative therapy of intervertebral disc: a double blind phase 2b trial of intradiscal injection of mesenchymal stromal cells in degenerative disc disease of the lomber SPINE unresponsive to conventional therapy

    Horizon 2020 · 2017–2023 · Project on CORDIS ↗

    €308ktheir share
  • Digi-NewBAssociated partner

    Non-invasive monitoring of perinatal health through multiparametric digital representation of clinically relevant functions for improving clinical intervention in neonatal units (Digi-NewB)

    Horizon 2020 · 2016–2020 · Project on CORDIS ↗

  • BETA3_LVHPartner

    A multi-center randomized, placebo-controlled trial of mirabegron, a new beta3-adrenergic receptor agonist on left ventricular mass and diastolic function in patients with structural heart disease

    Horizon 2020 · 2015–2022 · Project on CORDIS ↗

    €251ktheir share
  • TRANSLINKPartner

    Defining the role of xeno-directed and autoimmune events in patients receiving animal-derived bioprosthetic heart valves

    FP7 (2007 to 2013) · 2013–2018 · Project on CORDIS ↗

    €787ktheir share
  • BIO-DrIMPartner

    Personalized minimization of immunosuppression after solid organ transplantation by biomarker-driven stratification of patients to improve long-term outcome and health-economic data of transplantation

    FP7 (2007 to 2013) · 2012–2017 · Project on CORDIS ↗

    €500ktheir share
  • SYSCLADPartner

    Systems prediction of Chronic Lung Allograft Dysfunction

    FP7 (2007 to 2013) · 2012–2014 · Project on CORDIS ↗

    €849ktheir share
  • TRIADPartner

    Tolerance Restoration In Autoimmune Diseases by selective manipulation of the CD28 costimulatory pathway

    FP7 (2007 to 2013) · 2012–2014 · Project on CORDIS ↗

    €163ktheir share
  • THE ONE STUDYPartner

    A Unified Approach to Evaluating Cellular Immunotherapy in Solid Organ Transplantation

    FP7 (2007 to 2013) · 2010–2017 · Project on CORDIS ↗

    €678ktheir share
  • REBORNEPartner

    Regenerating Bone defects using New biomedical Engineering approaches

    FP7 (2007 to 2013) · 2010–2015 · Project on CORDIS ↗

    €100ktheir share
  • LOULLA&PHILLAPartner

    Development of 6-mercaptopurine and Methotrexate oral liquid formulations for the maintenance treatment of Acute Lymphoblastic Leukæmia in children

    FP7 (2007 to 2013) · 2008–2012 · Project on CORDIS ↗

    €46ktheir share

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

Fields it works in

Research fields recorded on its Horizon projects.

  • DNA
  • alkali metals
  • antibiotic resistance
  • antibiotics
  • arteriosclerosis
  • artificial bone
  • asthma
  • autoimmune diseases
  • bladder cancer
  • carbohydrates
  • cardiac arrhythmia
  • cardiovascular diseases
  • cells technologies
  • databases

Is this your organisation?

Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.

Claim this profile →

Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships. Official website ↗

Europe’s tech funding.
One place.

The weekly briefing

Funding calls, VC news and key deadlines — a weekly briefing for European founders.

Free · unsubscribe anytime